Latest Breaking News On - European society of cardiology - Page 5 : comparemela.com

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics.

United statesNathalie altermattJay bradnerSabine borngrKarsten kleineRebekka schnellSimon goldsboroughLoren kalmBirgit masjostKirti pandeyYvette petillonSileia urechBruno eschliColl cardiolMatt sauseRoche group

F Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) - a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics Tina-quant®

United statesMatt sauseSabine borngrKarsten kleineRebekka schnellSimon goldsboroughBirgit masjostYvette petillonJay bradnerNathalie altermattSileia urechLoren kalmKirti pandeyBruno eschliEuropean society of cardiologyCanadian cardiovascular society

Athletes With Heart Problems Can Continue to Play

An updated consensus statement for managing arrhythmias in athletes focuses on return to play and shared decision-making.

United statesUniversity of utahSalt lake cityEugene chungAmerican college of cardiologyUniversity of utah school medicineAmerican heart associationEuropean society of cardiologyHeart rhythm societyHeart rhythmMassachusetts general hospitalAmerican collegeEuropean societyUtah school

Daiichi Sankyo Europe GmbH: First-in-class cholesterol-lowering treatment NILEMDO? and its combination with ezetimibe, NUSTENDI?, approved in Europe to lower LDL cholesterol and reduce cardiovascular risk

NILEMDO? (bempedoic acid), a first-in-class, oral treatment and NUSTENDI? (bempedoic acid ezetimibe fixed-dose combination) receive label update approval from the European Commission as treatments

United kingdomDaiichi sankyo europe gmbSheldon koenigAlberico catapanoGillian dsouzaDaiichi sankyoOliver appelhansDaiichi sankyo europeUniversity of milanEuropean atherosclerosis societyEuropean society of cardiologyEuropean medicines agencyEuropean commissionHead of europe specialty divisionEsperion therapeutics incEuropean commissionas

Regular use of fish oil supplements could increase the risk of heart disease and stroke

Regular use of fish oil supplements could increase the risk of heart disease and stroke
ruetir.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ruetir.com Daily Mail and Mail on Sunday newspapers.

United statesSalvatore carboneEuropean society of cardiologySmidt heart instituteVirginia commonwealth universityDepartment of cardiologyKingdom biobank studyEuropean heart journalEuropean societyHarold kapelovitz distinguished chair